Suven Pharmaceuticals Ltd. - Research Center
543064 SUVENPHAR Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 25.46 | 25.46 | 25.46 | 12.73 | 12.73 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 1,723.92 | 1,495.24 | 1,039.73 | 770.10 | 577.56 |
| Loan funds | |||||
| Secured loans | 69.16 | 95.57 | 141.23 | 185.29 | 82.79 |
| Unsecured loans | - | - | - | - | - |
| Total | 1,818.54 | 1,616.27 | 1,206.41 | 968.12 | 673.08 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 710.83 | 692.04 | 567.38 | 455.66 | 346.77 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 198.80 | 157.84 | 126.22 | 98.92 | 75.87 |
| Net block | 512.03 | 534.19 | 441.16 | 356.74 | 270.90 |
| Capital work-in-progress | 164.81 | 29.99 | 96.32 | 101.71 | 111.07 |
| Investments | 710.06 | 599.90 | 426.24 | 276.32 | 7.13 |
| Net current assets | |||||
| Current assets, loans & advances | 571.43 | 640.81 | 395.11 | 376.11 | 393.92 |
| Less : current liabilities & provisions | 139.79 | 188.62 | 152.42 | 142.76 | 109.93 |
| Total net current assets | 431.64 | 452.18 | 242.69 | 233.35 | 283.99 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 1,818.54 | 1,616.27 | 1,206.41 | 968.12 | 673.08 |
| Notes: | |||||
| Book value of unquoted investments | 710.06 | 599.90 | 426.24 | 276.32 | 7.13 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 190.84 | 29.38 | 47.70 | 78.83 | 10.84 |
| Number of equity sharesoutstanding (Lacs) | 2545.65 | 2545.65 | 2545.65 | 1272.82 | 1272.82 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis